Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Instil Bio, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 58 | 30 | −28 |
| SharesConverted for a 1-for-20 split | 4.01M | 3.94M | −74.4K (−1.9%) |
| Value | $34.3M | $30.0M | −$4.34M (−12.6%) |
New holders (2)
Institutions that held Instil Bio, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cable Car Capital LLC | 258,097 | $1.97M | 2.06% |
| Anson Funds Management LP | 17,344 | $132.2K | 0.03% |
Sold out (30)
Institutions that held Instil Bio, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.